| Infliximab | ||
| Flixabi, Samsung Bioepis | ||
| 1 fl ev 100 mg | € 637,52 | H-RLR |
| Remicade, Janssen Biologics B.V. | ||
| 1 fl 100 mg per infus ev | € 765,03 | H-RLR |
| Remsima, Celltrion Healthcare Hung. KFT | ||
| 1 fl ev 100 mg | € 637,52 | H-RLR |
| 4 fl ev 100 mg | € 2550,07 | H-RLR |
| 1 pen sc 1 ml 120 mg/ml | € 476,95 | H-RLR |
| 4 pen sc 1 ml 120 mg/ml | € 1907,76 | H-RLR |
| Zessly, Sandoz | ||
| 1 fl ev 100 mg | € 637,52 | H-RLR |